Non-Small Cell Lung Cancer

Bristol Myers to Use Microsoft’s Imaging Network to Deploy FDA-Cleared AI for Earlier Lung Cancer Detection

The effort targets underserved U.S. hospitals by embedding AI in routine imaging workflows for faster referral to precision care.